Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
The DOI matches its Crossref record; 218 of the 218 references it cites were found in a registry or an index.
Abstract
The BCL-2 protein family determines the commitment of cells to apoptosis, an ancient cell suicide programme that is essential for development, tissue homeostasis and immunity. Too little apoptosis can promote cancer and autoimmune diseases; too much apoptosis can augment ischaemic conditions and drive neurodegeneration. We discuss the biochemical, structural and genetic studies that have clarified how the interplay between members of the BCL-2 family on mitochondria sets the apoptotic threshold. These mechanistic insights into the functions of the BCL-2 family are illuminating the physiological control of apoptosis, the pathological consequences of its dysregulation and the promising search for novel cancer therapies that target the BCL-2 family.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Together with BOK, BCL2 family apoptosis regulator (BOK) [47], BAX and BAK are the only BCL2 family members characterized so far in mammalian cells for their ability to form pores across the outer mitochondrial membrane (OMM) and possibly other intracellular membranes [29, 42, 43].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [29]
In the citing paper
“which is controlled by pro-apoptotic and anti-apoptotic members of the BCL2, apoptosis regulator (BCL2) protein family, a group of proteins sharing one to four BCL2 homology (BH) domains (i.e., BH1, BH2, BH3, and BH4) [29, 42, 43].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [29]
In the citing paper
“Intrinsic apoptosis is a form of RCD initiated by a variety of microenvironmental perturbations including (but not limited to) growth factor withdrawal, DNA damage, endoplasmic reticulum (ER) stress, reactive oxygen species (ROS) overload, replication stress, microtubular alterations or mitotic defects [29–34].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [29]
In the citing paper
“MOMP is antagonized by anti-apoptotic members of the BCL2 family, including BCL2 itself, BCL2 like 1 (BCL2L1; best known as BCL-XL), MCL1, BCL2 family apoptosis regulator (MCL1), BCL2 like 2 (BCL2L2; best known as BCL-W), and BCL2 related protein A1 (BCL2A1; best known—in human—as BFL-1) [29, 42, 43].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [29]
In the citing paper
“Thus, most pro-survival BCL2 family members inhibit BAX and BAK by preventing their oligomerization and pore-forming activity either directly, upon physical sequestration at the OMM, or indirectly, following the sequestration of BH3-only activators [29, 64, 79, 110].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [29]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972) · British Journal of Cancer · doi:10.1038/bjc.1972.33 · Cited by 15,725
Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., & Wang, X. (1997) · Cell · doi:10.1016/s0092-8674(00)80434-1 · Cited by 7,289
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death
Oltval, Z. N., Milliman, C. L., & Korsmeyer, S. J. (1993) · Cell · doi:10.1016/0092-8674(93)90509-o · Cited by 6,003
The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis
Kluck, R. M., Bossy-Wetzel, E., Green, D. R., & Newmeyer, D. D. (1997) · Science · doi:10.1126/science.275.5303.1132 · Cited by 4,714
The BCL-2 protein family: opposing activities that mediate cell death
Youle, R. J., & Strasser, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2308 · Cited by 4,679
Self-citationThe landscape of somatic copy-number alteration across human cancers
Beroukhim, R., Mermel, C. H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., Barretina, J., Boehm, J. S., Dobson, J., Urashima, M., et al. (2010) · Nature · doi:10.1038/nature08822 · Cited by 4,017
Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death
Wei, M. C., Zong, W.-X., Cheng, E. H.-Y., Lindsten, T., Panoutsakopoulou, V., Ross, A. J., Roth, K. A., MacGregor, G. R., Thompson, C. B., & Korsmeyer, S. J. (2001) · Science · doi:10.1126/science.1059108 · Cited by 3,988
Du, C., Fang, M., Li, Y., Li, L., & Wang, X. (2000) · Cell · doi:10.1016/s0092-8674(00)00008-8 · Cited by 3,513
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,416
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
Vaux, D. L., Cory, S., & Adams, J. M. (1988) · Nature · doi:10.1038/335440a0 · Cited by 3,219
Self-citation
Cited by
Items 301–400 of 1,008
Long Non-coding RNA in CNS Injuries: A New Target for Therapeutic Intervention
Zhang, L., & Wang, H. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.07.013 · Cited by 105
“Once caspase-8 is activated, the execution phase of apoptosis is triggered.(76) Therefore, the apoptotic pathway that is associated with the effects of lncRNAs on apoptosis remains unclear and further studies are needed to clarify it.”
BackgroundDifferent modalities of host cell death and their impact on Mycobacterium tuberculosis infection
Nisa, A., Kipper, F. C., Panigrahy, D., Tiwari, S., Kupz, A., & Subbian, S. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00246.2022 · Cited by 116
Long noncoding RNA FTX regulates cardiomyocyte apoptosis by targeting miR-29b-1-5p and Bcl2l2
Long, B., Li, N., Xu, X., Li, X., Xu, X., Guo, D., Zhang, D., Wu, Z., & Zhang, S. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.11.030 · Cited by 112
“Bc l2l2 is also known as Bcl-w which is an anti-apoptotic protein controlling the survival of cells [5,6].”
BackgroundMolecular Comprehension of Mcl-1: From Gene Structure to Cancer Therapy
Senichkin, V. V., Streletskaia, A. Y., Zhivotovsky, B., & Kopeina, G. S. (2019) · Trends in Cell Biology · doi:10.1016/j.tcb.2019.03.004 · Cited by 109
Drug mechanism‐of‐action discovery through the integration of pharmacological and CRISPR screens
Gonçalves, E., Segura‐Cabrera, A., Pacini, C., Picco, G., Behan, F. M., Jaaks, P., Coker, E. A., van der Meer, D., Barthorpe, A., Lightfoot, H., et al. (2020) · Molecular Systems Biology · doi:10.15252/msb.20199405 · Cited by 101
“Next, we used multilinear regression models to predict sensitivity to each MCL1 inhibitor using gene fitness and/or gene expression of known regulators of MCL1 (e.g. BCL2, BCL2L1, BAX) (Czabotar et al, 2014) and MARCH5.”
MethodSaddam, M., Paul, S. K., Habib, M. A., Fahim, M. A., Mimi, A. A., Islam, S., Paul, B., & Helal, M. M. U. (2024) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-024-00485-7 · Cited by 123
“Their fundamental individual roles as well as some of their overlapping func - tions have been explained via gene disruption [47].”
BackgroundInfluentialMukherjee, A., & Williams, D. W. (2017) · Cell Death & Differentiation · doi:10.1038/cdd.2017.64 · Cited by 100
“The proapoptotic BH3-only proteins activate Bax/Bak directly or indirectly by inhibition of the antiapoptotic Bcl2 proteins (reviewed in Czabotar et al.(3)).”
BackgroundVenetoclax: A new wave in hematooncology
Mihályová, J., Jelínek, T., Growková, K., Hrdinka, M., Šimíček, M., & Hájek, R. (2018) · Experimental Hematology · doi:10.1016/j.exphem.2018.02.002 · Cited by 110
Of the many cellular responses activated by TP53, which ones are critical for tumour suppression?
Thomas, A., Kelly, G. L., & Strasser, A. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-00996-z · Cited by 110
“There are two distinct but ultimately converging pathways to apoptosis: the BCL-2 regulated (aka mitochondrial or intrinsic) pathway [21] and the death receptor induced (aka extrinsic) pathway [22].”
BackgroundSelf-citationMitochondria and apoptosis: emerging concepts
Li, X., & Dewson, G. (2015) · F1000Prime Reports · doi:10.12703/p7-42 · Cited by 117
“That the pro-apoptotic effector proteins BAX and BAK become activated during apoptosis and are necessary for apoptotic cell death has led to the recognition of these proteins as valuable therapeutic targets either to activate their deadly function to induce cell death for cancer therapy or to block their activity to i…”
BackgroundYang, J., Zhao, W., & Chen, D. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.06.086 · Cited by 104
Li, X., Luo, S., Zhang, J., Yuan, Y., Jiang, W., Zhu, H., Ding, X., Zhan, L., Wu, H., Xie, Y., et al. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.05.031 · Cited by 104
“Mitochondrial Apoptotic Pathway The Bcl-2 protein family determines the fate of cells to apoptosis.(31) Reduction of the Bcl-2/Bax ratio can trigger cytochrome c (Cyt-c) release from mitochondria to activate caspase-9 and eventually activate caspase-3, an executioner of apoptotic cell death.”
Mardi, A., Shirokova, A. V., Mohammed, R. N., Keshavarz, A., Zekiy, A. O., Thangavelu, L. P., Mohammad, T. A. M., Marofi, F., Shomali, N., Zamani, A., et al. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02585-z · Cited by 109
The design and development of covalent protein-protein interaction inhibitors for cancer treatment
Cheng, S.-S., Yang, G.-J., Wang, W., Leung, C.-H., & Ma, D.-L. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00850-0 · Cited by 98
“Moreover, the inhibitor could target endogenous Grb2 and significantly inhibit mobility and viability in SK-BR-3 human breast cancer cells [95].”
BackgroundERK2 Mediates Metabolic Stress Response to Regulate Cell Fate
Shin, S., Buel, G. R., Wolgamott, L., Plas, D. R., Asara, J. M., Blenis, J., & Yoon, S.-O. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.06.020 · Cited by 100
“Bid regulates mitochondrial apoptotic pathway and amplifies caspase signaling (Czabotar et al., 2014).”
Regulation of platelet lifespan by apoptosis
Lebois, M., & Josefsson, E. C. (2016) · Platelets · doi:10.3109/09537104.2016.1161739 · Cited by 108
“cells to be rapidly removed without triggering inflammation [6, 7].”
Dey, J., Deckwerth, T. L., Kerwin, W. S., Casalini, J. R., Merrell, A., Grenley, M. O., Burns, C., Ditzler, S. H., Dixon, C., Beirne, E., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-18368-w · Cited by 99
AML treatment: conventional chemotherapy and emerging novel agents
Forsberg, M., & Konopleva, M. Y. (2024) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2024.03.005 · Cited by 120
Overexpression of B7-H3 augments anti-apoptosis of colorectal cancer cells by Jak2-STAT3
Zhang, T., Jiang, B., Zou, S.-T., Liu, F., & Hua, D. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i6.1804 · Cited by 101
Chen, Z., Xu, Q.-Q., Shan, C.-S., Shi, Y., Wang, Y., Chang, R. C., & Zheng, G. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/2936737 · Cited by 106
Humanin: A mitochondrial-derived peptide in the treatment of apoptosis-related diseases
Hazafa, A., Batool, A., Ahmad, S., Amjad, M., Chaudhry, S. N., Asad, J., Ghuman, H. F., Khan, H. M., Naeem, M., & Ghani, U. (2021) · Life Sciences · doi:10.1016/j.lfs.2020.118679 · Cited by 95
Decoding immunogenic cell death from a dendritic cell perspective
Janssens, S., Rennen, S., & Agostinis, P. (2023) · Immunological Reviews · doi:10.1111/imr.13301 · Cited by 113
“134,135 This event unleashes the proapoptotic pore-forming activity of BAX and BAK, resulting in MOMP.”
BackgroundRegulation of mitochondrial nutrient and energy metabolism by BCL-2 family proteins
Giménez-Cassina, A., & Danial, N. N. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.02.004 · Cited by 94
“BH3-only proteins are cell death initiators whose pro-apoptotic activity is latent unless activated by transcriptional or post-translational mechanisms in a tissue-restricted and signal-specific manner [2, 4, 5].”
BackgroundInfluentialRegulation of programmed cell death by Brd4
Hu, J., Pan, D., Guo, L., Chen, K., & Hu, X. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05505-1 · Cited by 105
“The pro-survival and pro-apoptotic BCL-2 family proteins determine the commitment of cells to apoptosis, making the life-or-death decision for cells [35].”
BackgroundHe, R., Liu, Y., Fu, W., He, X., Liu, S., Xiao, D., & Tao, Y. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02172-y · Cited by 122
Hockings, C., Anwari, K., Ninnis, R. L., Brouwer, J., O'Hely, M., Evangelista, M., Hinds, M. G., Czabotar, P. E., Lee, E. F., Fairlie, W. D., et al. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.105 · Cited by 94
Self-citationCheng, C.-Y., Tang, N.-Y., Kao, S.-T., & Hsieh, C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155748 · Cited by 95
“The Bcl-2 protein family is classified into three structurally distinct subgroups: antiapoptotic proteins such as Bcl-2 and Bcl-xL, proapoptotic proteins such as Bax, and Bcl-2 homology 3 (BH3)-only proteins such as Bad [46,47].”
BackgroundCrosstalk between apoptosis and autophagy signaling pathways
(2020) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2020.01.003 · Cited by 92
BH3‐in‐groove dimerization initiates and helix 9 dimerization expands Bax pore assembly in membranes
Zhang, Z., Subramaniam, S., Kale, J., Liao, C., Huang, B., Brahmbhatt, H., Condon, S. G., Lapolla, S. M., Hays, F. A., Ding, J., et al. (2016) · The EMBO Journal · doi:10.15252/embj.201591552 · Cited by 93
“The protein complexes and conformations that we have characterized here may be potential targets for the future development of apoptotic modulators to eradicate cancer or to prevent ischemia reperfusion injury (Czabotar et al , 2014; Moldoveanu et al , 2014; Brahmbhatt et al , 2015).”
Yue, W., Zheng, X., Lin, Y., Yang, C. S., Xu, Q., Carpizo, D. R., Huang, H., DiPaola, R. S., & Tan, X. (2015) · Oncotarget · doi:10.18632/oncotarget.4126 · Cited by 103
“These results are consistent with the idea that that particular BH3-only proteins drive the responses to specific cytotoxic insults, with Bim and Puma often being essential [31].”
Restoration of mitochondria function as a target for cancer therapy
Bhat, T. A., Kumar, S., Chaudhary, A. K., Yadav, N., & Chandra, D. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.03.001 · Cited by 105
Weeden, C. E., Ah-Cann, C., Holik, A. Z., Pasquet, J., Garnier, J.-M., Mérino, D., Lessène, G., & Asselin-Labat, M.-L. (2018) · Oncogene · doi:10.1038/s41388-018-0268-2 · Cited by 97
Brennan, M. S., Chang, C. W. T., Dewson, G., Tai, L., Lessène, G., Strasser, A., Kelly, G. L., & Herold, M. J. (2018) · Blood · doi:10.1182/blood-2018-06-859405 · Cited by 95
Self-citationApoptotic Pathway as the Therapeutic Target for Anticancer Traditional Chinese Medicines
An, W., Lai, H., Zhang, Y., Liu, M., Lin, X., & Cao, S. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00758 · Cited by 101
Mitochondrial and metabolic alterations in cancer cells
Gregorio, J. D., Petricca, S., Iorio, R., Toniato, E., & Flati, V. (2022) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2022.151225 · Cited by 101
MiR-449a regulates autophagy to inhibit silica-induced pulmonary fibrosis through targeting Bcl2
Han, R., Ji, X., Rong, R., Li, Y., Yao, W., Yuan, J., Wu, Q., Yang, J., Yan, W., Han, L., et al. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1441-0 · Cited by 94
“Bcl2 is an important antiapoptotic regulator protein [26].”
BackgroundAging‐related Atg5 defect impairs neutrophil extracellular traps formation
Xu, F., Zhang, C., Zou, Z., Fan, E., Chen, L., Li, Y., Billiar, T. R., Wilson, M. A., Shi, X., & Fan, J. (2017) · Immunology · doi:10.1111/imm.12740 · Cited by 98
Han, B., Jiang, P., Li, Z., Yu, Y., Huang, T., Ye, X., & Li, X. (2017) · Phytomedicine · doi:10.1016/j.phymed.2017.12.027 · Cited by 100
Gytz, H., Hansen, M. F., Skovbjerg, S., Kristensen, A. C. M., Hørlyck, S., Jensen, M. B., Fredborg, M., Markert, L. D., McMillan, N. A. J., Christensen, E., et al. (2016) · Biology of the Cell · doi:10.1111/boc.201600034 · Cited by 112
“The “constant growing” Bcl-2 family of proteins comprises more than 20 members in humans and is characterised by the presence of at least one of the four Bcl-2 homology (BH) domains, designated as BH1–BH4 (Chipuk et al., 2010; Hardwick and Soane, 2013; Czabotar et al., 2014).”
BackgroundSingh, A. P., Glennon, M. S., Umbarkar, P., Gupte, M., Galindo, C. L., Zhang, Q., Force, T. L., Becker, J. R., & Lal, H. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz006 · Cited by 96
Intracellular Transport and Cytotoxicity of the Protein Toxin Ricin
Sowa-Rogozińska, N., Sominka, H., Nowakowska-Gołacka, J., Sandvig, K., & Słomińska-Wojewódzka, M. (2019) · Toxins · doi:10.3390/toxins11060350 · Cited by 98
“This family of proteins consists of three subfamilies playing opposing functions in this process: proapoptotic BH3-only members (Bim, Bid, Puma, Noxa, Hrk, Bmf, and Bad), proapoptotic effector molecules (Bax and Bak), and antiapoptotic Bcl-2 family proteins (Bcl-2, Bcl-xL, Mcl1, A1, and Bcl-B) [244,245,249].”
BackgroundProgrammed cell death in aortic aneurysm and dissection: A potential therapeutic target
Chakraborty, A., Yang, L., Zhang, C., Li, Y., LeMaire, S. A., & Shen, Y. H. (2021) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2021.09.010 · Cited by 108
“: The intrinsic apoptosis pathway, also called the mitochondrial pathway because of the essential involvement of mitochondria, is primarily regulated by proteins in the Bcl family, which contains proapoptotic BH3-only members (Bim, Bid, Puma, Noxa, Hrk, Bmf, and Bad), proapoptotic effector molecules (Bax and Bak), and…”
BackgroundZhang, M., Mathews Griner, L. A., Ju, W., Duveau, D. Y., Guha, R., Petrus, M. N., Wen, B., Maeda, M., Shinn, P., Ferrer, M., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516208112 · Cited by 92
“Once activated, Bax and Bak induce permeabilization of the mitochondrial outer membrane and subsequent release of apoptogenic molecules such as cytochrome c, which leads to caspase activation (24, 26).”
BackgroundGAO, Z.-Y., Liu, Z., Bi, M., Zhang, J., Han, Z., Han, X., WANG, H.-Y., Sun, G., & Liu, H. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3143 · Cited by 98
“Apoptosis suppresses cell proliferation (27), and the BCL-2 family of proteins plays an important role in the response to apoptosis of different cell types, including myocardial, endothelial and cancer cells (28-31).”
Bad phosphorylation as a target of inhibition in oncology
Bui, N.-L.-C., Pandey, V., Zhu, T., Ma, L., Basappa, & Lobie, P. E. (2018) · Cancer Letters · doi:10.1016/j.canlet.2017.11.017 · Cited by 86
“There are three subfamilies in the Bcl-2 family namely, 1) Initiators: BH3 only proteins (BIM, PUMA, BAD, NOXA, BIK, HRK, BMF and tBID) 2) Guardians: anti-apoptotic proteins (Bcl-2, Bcl-XL, Bcl-W, Mcl-1, A1, Bcl-B) 3) Effectors: pro- apoptotic proteins (BAX, BAK, BOK)[12].”
BackgroundInfluentialSheikh, B. Y., Sarker, M. M. R., Kamarudin, M. N. A., & Mohan, G. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.10.038 · Cited by 102
“Apoptosis hold the cardinal role in the normal physiological and homeostasis processes as well as defense mechanisms against various insults that is systematically orchestrated which will result in the demise of the older or damaged cell [39,55].”
BackgroundBH3-dependent and independent activation of BAX and BAK in mitochondrial apoptosis
Jeng, P., Inoue‐Yamauchi, A., Hsieh, J. J.-D., & Cheng, E. H. Y. (2018) · Current Opinion in Physiology · doi:10.1016/j.cophys.2018.03.005 · Cited by 103
The emerging role of noncoding RNAs in colorectal cancer chemoresistance
Wei, L., Wang, X., Lv, L., Zheng, Y., Zhang, N., & Yang, M. (2019) · Cellular Oncology · doi:10.1007/s13402-019-00466-8 · Cited by 91
Predicting and Experimentally Validating Hot-Spot Residues at Protein–Protein Interfaces
Ibarra, A. Á., Bartlett, G. J., Hegedüs, Z., Dutt, S., Hóbor, F., Horner, K. A., Hetherington, K., Spence, K., Nelson, A. S., Edwards, T. A., et al. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00560 · Cited by 109
Denis, C., Santos, J. S. O., Bureau, R., & Voisin‐Chiret, A. S. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00983 · Cited by 99
Pan, Y., Wu, W., Jiang, X., & Liu, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114817 · Cited by 107
Perturbing mitosis for anti‐cancer therapy: is cell death the only answer?
Haschka, M. D., Karbon, G., Fava, L. L., & Villunger, A. (2018) · EMBO Reports · doi:10.15252/embr.201745440 · Cited by 105
Multiple myeloma with 1q21 amplification is highly sensitive to MCL-1 targeting
Slomp, A., Moesbergen, L. M., Gong, J., Cuenca, M., Borne, P. A. V. D., Sonneveld, P., Huang, D. C. S., Minnema, M. C., & Peperzak, V. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000702 · Cited by 93
“BH3 mimetics overcome apoptosis resistance by binding and inhibiting select prosurvival BCL-2 family proteins.(6,7) BCL-2 family proteins are key mediators of the intrinsic apoptosis pathway.”
BackgroundKill one or kill the many: interplay between mitophagy and apoptosis
Wanderoy, S., Hees, J. T., Klesse, R., Edlich, F., & Harbauer, A. B. (2020) · Biological Chemistry · doi:10.1515/hsz-2020-0231 · Cited by 98
Graphene oxide nanoarchitectures in cancer biology: Nano-modulators of autophagy and apoptosis
Taheriazam, A., Abad, G. G. Y., Hajimazdarany, S., Imani, M. H., Ziaolhagh, S., Zandieh, M. A., Bayanzadeh, S. D., Mirzaei, S., Hamblin, M. R., Entezari, M., et al. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.01.028 · Cited by 96
Liu, L.-X., Heng, J.-H., Deng, D.-X., Zhao, H., Zheng, Z.-Y., Liao, L., Lin, W., Xu, X., Li, E., & Xu, L. (2023) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2023.100551 · Cited by 97
Sulfatase-Induced In Situ Formulation of Antineoplastic Supra-PROTACs
Chen, N., Zhang, Z., Liu, X., Wang, H., Guo, R.-C., Wang, H., Hu, B., Shi, Y., Zhang, P., Liu, Z., et al. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c00826 · Cited by 91
Engert, F., Kovac, M. B., Baumhoer, D., Nathrath, M., & Fulda, S. (2016) · Oncotarget · doi:10.18632/oncotarget.10720 · Cited by 94
“Next, we asked whether talazoparib and TMZ cooperate to activate BAK and BAX, two multidomain proapoptotic BCL-2 proteins that control MOMP [15].”
MGMT-activated DUB3 stabilizes MCL1 and drives chemoresistance in ovarian cancer
Wu, X., Luo, Q., Zhao, P., Chang, W., Wang, Y., Shu, T., Ding, F., Li, B., & Liu, Z. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1814742116 · Cited by 89
“The B-cell lymphoma 2 (BCL-2) family encodes more than 20 proteins, including proapoptotic and antiapoptotic proteins that regulate the intrinsic apoptosis pathway, which maintains the balance between cell survival and cell death (3).”
BackgroundFadaly, W. A. A., Elshaier, Y. A. M. M., Hassanein, E. H. M., & Abdellatif, K. R. A. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.103752 · Cited by 92
Ren, L., Wan, L., Zheng, X., Liu, J.-Y., Yang, Y., Li, S., Zhang, S., Fu, W.-Q., Xiao, B., Wang, J., et al. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00752-y · Cited by 98
Chaudhary, A. K., Yadav, N., Bhat, T. A., O’Malley, J., Kumar, S., & Chandra, D. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2015.07.014 · Cited by 88
“The proapoptotic BH3-only proteins such as Bim and Bid activate Bax and Bak causing their oligomerization and channel formation [82].”
BackgroundExpression of the vault RNA protects cells from undergoing apoptosis
Amort, M., Nachbauer, B., Tuzlak, S., Kieser, A., Schepers, A., Villunger, A., & Polacek, N. (2015) · Nature Communications · doi:10.1038/ncomms8030 · Cited by 94
“…action of pro-apoptotic BH3-only proteins involved in intrinsic apoptosis, e.g. Bim, Puma, required for staurosporine or etoposide killing 48 , as well as Bid, connecting the mitochondrial pathway to death receptor mediated apoptosis in many cancer cells after caspase-8 mediated proteolysis 37 .”
Castillo, R. R., Baeza, A., & Vallet‐Regí, M. (2017) · Biomaterials Science · doi:10.1039/c6bm00872k · Cited by 89
Circu, M. L., Cardelli, J. A., Barr, M. P., O'Byrne, K. J., Mills, G. M., & El-Osta, H. E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184922 · Cited by 99
“It is believed that pore formation within the mitochondrial outer membrane, tightly regulated by a balance between various pro-apoptotic (such as Bax and Bak) and anti-apoptotic proteins of the Bcl-2 family, promotes the release of the mitochondrial apoptogenic proteins into the cytosol [14].”
BackgroundBH3-Only Proteins Noxa and Puma Are Key Regulators of Induced Apoptosis
Roufayel, R., Younes, K., Al-Sabi, A., & Murshid, N. (2022) · Life · doi:10.3390/life12020256 · Cited by 116
“Overexpression of Noxa in MEFs leads to Mcl-1 degradation without significant induction of apoptosis [66].”
BackgroundInfluentialLipid droplet‐targeted NIR AIE photosensitizer evoking concurrent ferroptosis and apoptosis
Jia, J., Ma, Z., Zhuang, J., Huo, L., Zhou, C., Li, N., & Zhao, N. (2024) · Aggregate · doi:10.1002/agt2.516 · Cited by 92
Yu, X., & He, S. (2016) · Virology Journal · doi:10.1186/s12985-016-0528-0 · Cited by 90
“The intrinsic apoptosis pathway is tightly regulated by the members of the Bcl-2 protein family, which can be divided into the anti-apoptotic Bcl-2 family members including Bcl-2, Bcl-xL, Mcl-1, and the proapoptotic Bcl-2 family members including Bid, Bax, and Bak [35].”
BackgroundNew Targeted Agents in Acute Myeloid Leukemia: New Hope on the Rise
Bohl, S., Bullinger, L., & Rücker, F. G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081983 · Cited by 97
Targeting Bcl-2 Proteins in Acute Myeloid Leukemia
Wei, Y., Cao, Y., Sun, R., Cheng, L., Xiong, X., Jin, X. K., He, X., Lu, W., & Zhao, M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.584974 · Cited by 100
Yang, D., Zhan, M., Chen, T., Chen, W., Zhang, Y., Xu, S., Yan, J., Huang, Q., & Wang, J. (2017) · Scientific Reports · doi:10.1038/srep43109 · Cited by 93
Zhang, X., Thummuri, D., He, Y., Liu, X., Zhang, P., Zhou, D., & Zheng, G. (2019) · Chemical Communications · doi:10.1039/c9cc07217a · Cited by 86
Tsuyama, N., Sakata, S., Baba, S., Mishima, Y. M., Nishimura, N., Ueda, K., Yokoyama, M., Terui, Y., Hatake, K., Kitagawa, M., et al. (2017) · Blood · doi:10.1182/blood-2016-12-759621 · Cited by 93
Balachandran, C., Haribabu, J., Jeyalakshmi, K., Bhuvanesh, N. S. P., Karvembu, R., Emi, N., & Awale, S. (2018) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2018.02.014 · Cited by 90
Wu, X., Luo, Q., & Liu, Z. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02760-y · Cited by 99
Khalil, M. A., Sonbol, F. I., Al-Madboly, L. A., Aboshady, T. A., Alqurashi, A. S., & Ali, S. S. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.803688 · Cited by 84
“As illustrated in Figure 10, polysaccharides exert their antitumor activity via two distinct mechanisms: the BCL2-regulated (also known as intrinsic, mitochondrial, or stress) pathway, which is activated by cytokine deprivation, ER stress, or DNA damage, and the death receptor (also known as extrinsic) pathway, which…”
BackgroundBarrère‐Lemaire, S., Vincent, A., Jørgensen, C., Piot, C. A., Nargeot, J., & Djouad, F. (2023) · Physiological Reviews · doi:10.1152/physrev.00009.2023 · Cited by 96
Gao, X., Zhang, J., Huang, Z., Zuo, T., Lu, Q., Wu, G., & Shen, Q. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b05119 · Cited by 85
Arnett, E., Weaver, A. M., Brito, K. C. W. D., Montoya, M. J., Li, M. M., Hoang, K. V., Hayhurst, A., Azad, A. K., & Schlesinger, L. S. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007100 · Cited by 91
Regulation of Apoptosis during Flavivirus Infection
Okamoto, T., Suzuki, T., Kusakabe, S., Tokunaga, M., Hirano, J., Miyata, Y., & Matsuura, Y. (2017) · Viruses · doi:10.3390/v9090243 · Cited by 95
Critical functions for STAT5 tetramers in the maturation and survival of natural killer cells
Lin, J., Du, N., Li, P., Kazemian, M., Gebregiorgis, T., Spolski, R. J., & Leonard, W. J. (2017) · Nature Communications · doi:10.1038/s41467-017-01477-5 · Cited by 84
Zhao, P., Yin, S., Qiu, Y., Sun, C., & Yu, H. (2025) · Molecular Cancer · doi:10.1186/s12943-024-02217-2 · Cited by 117
Lee, T.-H., Hirst, D. J., Kulkarni, K., Borgo, M. P. D., & Aguilar, M. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00729 · Cited by 89
Estrogen-Related Hormones Induce Apoptosis by Stabilizing Schlafen-12 Protein Turnover
Li, D., Chen, J., Ai, Y., Gu, X., Li, L., Che, D., Jiang, Z., Li, L., Chen, S., Huang, H., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.06.040 · Cited by 90
“The release of cytochrome c from mitochondria to cytosol is controlled by an evolutionarily conserved family of proteins that all share Bcl-2 homology (BH) domains (Czabotar et al., 2014).”
BackgroundMethodInfluentialEsteve‐Arenys, A., Valero, J. G., Chamorro-Jorganes, A., Gonzalez, D., Rodríguez, V., Dlouhy, I., Salaverría, I., Campo, E., Colomer, D., Martínez, A., et al. (2018) · Oncogene · doi:10.1038/s41388-017-0111-1 · Cited by 89
“This step is followed by the permeabilization of the mitochondrial outer membrane and the subsequent cytosolic release of cytochrome c and activation of caspases [24].”
BackgroundPan, X. Y., Zhao, Y., Hu, F.-Y., Chi, C., & Wang, B. (2016) · Marine Drugs · doi:10.3390/md14080153 · Cited by 82
“Consequently, the Bcl-2 family proteins play a pivotal role in determining whether a cell will live or die [23,24].”
BackgroundTargeting MCL-1 protein to treat cancer: opportunities and challenges
Tantawy, S. I., Timofeeva, N., Sarkar, A., & Gandhi, V. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1226289 · Cited by 90
“The direct, specific inhibitors of MCL-1’s protein-protein interactions have a similar structure to that of the BH3-only protein motifs and bind to MCL-1’s BH3 hydrophobic groove (112).”
BackgroundMitochondrial quality control in health and cardiovascular diseases
Atici, A. E., Crother, T. R., & Rivas, M. N. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1290046 · Cited by 92
“These factors reside on the OMM or ER and inhibit the binding of pro-apoptotic proteins (Czabotar et al., 2014).”
BackgroundLeptin Enhances TH2 and ILC2 Responses in Allergic Airway Disease
Zheng, H., Zhang, X., Castillo, E. F., Luo, Y., Liu, M., & Yang, X. O. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.743187 · Cited by 84
“Consistently, leptin treatment induced expression of an anti-apoptotic protein Bcl-2 that promotes cell survival (33) (Fig.”
BackgroundRabbani, N., Xue, M., Weickert, M. O., & Thornalley, P. J. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.05.006 · Cited by 92
Exploiting the pro-apoptotic function of NOXA as a therapeutic modality in cancer
Guikema, J. E. J., Amiot, M., & Eldering, E. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1349754 · Cited by 85
“However, upon binding with a Bcl-2-like member, the BH3-only domain is inserted into a hydrophobic groove of their binding partner [8].”
BackgroundMethodAraghi, R. R., Bird, G. H., Ryan, J. A., Jenson, J. M., Godes, M., Pritz, J. R., Grant, R. A., Letai, A. G., Walensky, L. D., & Keating, A. E. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1712952115 · Cited by 84
BIM Is the Primary Mediator of MYC-Induced Apoptosis in Multiple Solid Tissues
Muthalagu, N., Junttila, M. R., Wiese, K. E., Wolf, E., Morton, J. P., Bauer, B., Evan, G. I., Eilers, M., & Murphy, D. J. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.07.057 · Cited by 97
“In response to proapoptotic stimuli, BAX and BAK oligomerize to cause mitochondrial outer membrane permeabilization, triggering release of cytochrome c, SMAC/DIABLO, and consequent activation of effector caspases (Sarosiek et al., 2013b; Czabotar et al., 2014).”
Structural Insight into African Swine Fever Virus A179L-Mediated Inhibition of Apoptosis
Banjara, S., Caria, S., Dixon, L. K., Hinds, M. G., & Kvansakul, M. (2017) · Journal of Virology · doi:10.1128/jvi.02228-16 · Cited by 81
“apoptosis regulators from mitochondria (1, 2).”
Role and Regulation of Pro-survival BCL-2 Proteins in Multiple Myeloma
Slomp, A., & Peperzak, V. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00533 · Cited by 80
“The BCL-2 protein family consists of pro-survival BCL-2-like proteins (BCL-2, BCL-B, BCL-W, BCL-XL, BFL-1/A1, and MCL-1), pro-apoptotic BH3-only proteins (initiators), and pro-apoptotic effectors BAX, BAK (5), and possibly BOK (6–8).”
BackgroundInfluentialBacterial outer membrane vesicles and host cell death signaling
Dhital, S., Deo, P., Stuart, I., & Naderer, T. (2021) · Trends in Microbiology · doi:10.1016/j.tim.2021.04.003 · Cited by 85
Chen, P., Tang, G., Zhu, C., Sun, J., Wang, X., Xiang, M., Huang, H., Wang, W., Li, L., Zhang, Z., et al. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.2c11595 · Cited by 92
Pore formation by dimeric Bak and Bax: an unusual pore?
Uren, R. T., Iyer, S., & Kluck, R. M. (2017) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2016.0218 · Cited by 86
Zhu, L., Liu, Y., Wang, K., & Wang, N. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102629 · Cited by 97
Diverting CERT-mediated ceramide transport to mitochondria triggers Bax-dependent apoptosis
Jain, A., Beutel, O., Ebell, K., Korneev, S., & Holthuis, J. C. M. (2016) · Journal of Cell Science · doi:10.1242/jcs.194191 · Cited by 83
“DNA damage, cytokines) has been well established and provides an attractive target of therapeutic interventions (Czabotar et al., 2014; Tait and Green, 2013).”
Background
Metadata
- Authors
- Czabotar, P. E., Lessene, G., Strasser, A., & Adams, J. M.
- Affiliations
- The University of Melbourne (AU)
- Corresponding author
- Strasser, Andreas
- Adams, Jerry M.
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2013-12-20
- Volume
- 15
- Issue
- 1
- Pages
- 49-63
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W2088883749
- Cited by
- 3,219
- References
- 218
- Citations by year
- 2026: 164 · 2025: 220 · 2024: 249 · 2023: 230 · 2022: 265 · 2021: 319 · 2020: 299 · 2019: 285 · 2018: 314 · 2017: 292 · 2016: 287 · 2015: 209 · 2014: 77 · 2013: 1
- FWCI
- 18.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- Bcl-2 family proteins, apoptosis, mitochondrial outer membrane, BCL-2 inhibitor, cancer therapy, autoimmune disease, neurodegeneration, ischemia, apoptosis regulation
- MeSH terms
- Amino Acid Sequence, Animals, Humans, Models, Molecular, Molecular Sequence Data, Neoplasms, Signal Transduction, Apoptosis, Protein Structure, Secondary, Proto-Oncogene Proteins c-bcl-2, Apoptosis Regulatory Proteins, Protein Multimerization, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.